Text Size
219 studies found for:    vasculitis

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Recruiting IgA-positive Versus IgA-negative Immune Complex Vasculitis
Condition: Cutaneous Vasculitis
Intervention:
2 Completed Anti-Cytokine Therapy for Vasculitis
Conditions: Wegener's Granulomatosis;   Renal Limited Vasculitis;   Microscopic Polyangiitis
Interventions: Biological: Infliximab;   Drug: Cyclophosphamide;   Drug: Prednisolone;   Drug: Azathioprine;   Procedure: Plasma exchange;   Drug: Mycophenolate mofetil;   Drug: Methylprednisolone
3 Withdrawn Targeting Complement Activation in Antineutrophil Cytoplasmic Autoantibodies (ANCA)-Vasculitis - Eculizumab
Condition: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Interventions: Drug: Standard of care treatment;   Drug: eculizumab
4 Completed Ilaris® in Urticarial Vasculitis - Investigation of Treatment Responses
Conditions: Urticaria;   Vasculitis
Intervention: Drug: canakinumab
5 Recruiting Hematopoietic Stem Cell Support in Vasculitis
Condition: Vasculitis
Intervention: Biological: Autologous Hematopoietic Stem Cell Transplant
6 Completed MMF Versus CTX in the Induction Treatment of ANCA Associated Vasculitis
Conditions: Vasculitis;   Anti-Neutrophil Cytoplasmic Antibody
Intervention: Drug: mycophenolate mofetil
7 Recruiting Alemtuzumab for ANCA Associated Refractory Vasculitis
Conditions: Vasculitis;   Microscopic Polyangiitis;   Granulomatosis With Polyangiitis;   Wegener's
Intervention: Drug: Alemtuzumab
8 Recruiting Retinoids in ANCA Small Vessel Vasculitis: Silencing Autoantigens
Condition: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Interventions: Drug: Retinoic acid;   Drug: Standard of care
9 Recruiting American College of Rheumatology/European League Against Rheumatism (ACR/EULAR) Diagnostic and Classification Criteria for Primary Systemic Vasculitis
Conditions: Wegener's Granulomatosis;   Microscopic Polyangiitis;   Churg Strauss Syndrome;   Polyarteritis Nodosa;   Giant Cell Arteritis;   Takayasu Arteritis
Intervention:
10 Completed Pulse Versus Continuous Cyclophosphamide for Induction of Remission in ANCA-Associated Vasculitides
Conditions: ANCA Associated Systemic Vasculitis;   Wegener's Granulomatosis;   Microscopic Polyangiitis
Intervention: Drug: cyclophosphamide
11 Completed Steroids and Methotrexate to Treat Systemic Vasculitis
Conditions: Inflammation;   Vasculitis;   Wegener's Granulomatosis
Intervention: Drug: prednisone and methotrexate
12 Completed Evaluation of Clinical Efficacy and Immunologic Response After IL-2 Therapy in HCV-related Vasculitis Patients
Condition: Cryoglobulinemia Vasculitis
Intervention: Drug: Proleukin
13 Recruiting Prevention of Relapses in Proteinase 3 (PR3)-Anti-neutrophil Cytoplasmic Antibodies (ANCA)-Associated Vasculitis
Condition: Vasculitis
Intervention: Drug: azathioprine
14 Not yet recruiting Rituximab Vasculitis Maintenance Study
Conditions: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis;   Microscopic Polyangiitis;   Wegener Granulomatosis
Interventions: Biological: Rituximab;   Drug: Azathioprine
15 Terminated IMPROVE: Mycophenolate Mofetil Versus Azathioprine for Maintenance Therapy in ANCA Associated Systemic Vasculitis
Conditions: ANCA Associated Systemic Vasculitis Including Wegener’s;   Granulomatosis and Microscopic Polyangiitis and;   Renal Limited Vasculitis
Interventions: Drug: Cyclophosphamide;   Drug: Mycophenolate mofetil;   Drug: Azathioprine;   Drug: Prednisone (and methylprednisolone)
16 Completed Pilot Study of Rituximab Therapy for Systemic Lupus Erythematosus (SLE) and Vasculitis
Conditions: Systemic Lupus Erythematosus;   ANCA Associated Vasculitis
Intervention: Drug: Rituximab
17 Completed
Has Results 		Rituximab to Treat Hepatitis C-Associated Cryoglobulinemic Vasculitis
Conditions: Hepatitis C;   Vasculitis
Intervention: Drug: Rituximab
18 Unknown † Clinical Trial of Mycophenolate Versus Cyclophosphamide in ANCA Vasculitis
Condition: Vasculitis
Interventions: Drug: mycophenolate mofetil;   Drug: cyclophosphamide
19 Completed Correlation of Genetic Polymorphism and Livedo Vasculitis
Conditions: Livedo Vasculitis;   Livedoid Vasculitis;   Livedoid Vasculopathy;   Genetic Pleomorphism;   Leiden Mutation
Intervention:
20 Completed Biological Markers in Retinal Vasculitis
Condition: Retinal Vasculitis
Intervention:
To Top

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
† Indicates status has not been verified in more than two years